Search | IOVS | ARVO Journals

Showing 1 – 20 of 37

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

Repeatability of Best Corrected Visual Acuity (BCVA) and Ellipsoid Zone (EZ) width in eyes with Retinitis Pigmentosa (RP)

Zainab Rustam; Guoshu Kong; Folahan Adesola Ibukun; David G Birch; Ian Han; Rachel M Huckfeldt; Laura Kuehlewein; Kristina Pfau; Sandeep Grover; Lea D Bennett; Nieraj Jain; Kaitlyn A Sapoznik; Shivani Kochhar; Michael Lien; Aliya Siddiqui; Joseph Carroll; Michel Michaelides; Suzanne Yzer; Robert K Koenekoop; Tomas S Aleman; Byron L Lam; Richard N Sather; Nancy Aychoua; Sina Farsiu; Kevin Choy

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):3158.

ARVO Annual Meeting Abstract June 2025

Evaluation of Artificial Intelligence-Derived Peripapillary and Parafoveal Retinal Vessel Features for Cardiovascular Risk Prediction: Insights from the CRIC Study

Mendel Lebowitz; Rohan Dhamdhere; Gourav Modanwal; Amritpal Singh; Sruthi Arepalli; Nieraj Jain; Mahboob Rahman; Sadeer Al-Kindi; Anant Madabhushi

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):5459.

ARVO Annual Meeting Abstract June 2025

Pars Plana Vitrectomy in Congenital X-Linked Retinoschisis

Sakshi Shiromani; Kevin Ferenchak; Nieraj Jain

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):6050.

ARVO Annual Meeting Abstract June 2025

Vitreous Abnormalities in Retinitis Pigmentosa

Hossein Ameri; Zainab Rustam; Folahan Ibukun; Nieraj Jain; Ian Han; Sandeep Grover; Shivani Kochhar; Vinit B Mahajan; Hailey Ahrens; Roxanna Rabiee; Sandra Montezuma; Nancy Aychoua; Sun Young Lee; Rupert Strauss; Laura Kuehlewein; Peter A Campochiaro; Xiangrong Kong

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):1942.

ARVO Annual Meeting Abstract June 2025

Nonparaneoplastic Autoimmune Retinopathy: Scoping Review and Suggested Reporting Guidelines

Daniel Adamkiewicz; Kubra Sarici; H. Ayesha Hossain; Nieraj Jain

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):4695.

ARVO Annual Meeting Abstract June 2025

Factors associated with microperimetry false positive responses in patients with retinitis pigmentosa (RP)

Rachel M Huckfeldt; Yanzhao WANG; Ahmad al-Moujahed; Kirill Zaslavsky; Hossein Ameri; Nancy Aychoua; Artur V Cideciyan; Thales A C de Guimarães; Jacque L Duncan; Sandeep Grover; Folahan Ibukun; Nieraj Jain; Robert K Koenekoop; Byron L Lam; Michel Michaelides; Kristina Pfau; Zainab Rustam; Peter A Campochiaro; Xiangrong Kong

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):1941.

ARVO Annual Meeting Abstract June 2024

Phenotypic Spectrum of Retinal Degeneration in X-Linked PRPS1 -Related Retinopathy

Ogul Uner; Radwa Elsharawi; Margaret Reynolds; Giacomo Bacci; Sara Bargiacchi; Fred Chen; Nieraj Jain; Rachael C Heath Jeffery; Mariana Matioli de Palma; Juliana M F Sallum; Mariam Torres Soto; Kaylie D Webb-Jones; Paul Yang; Mark E Pennesi; Lesley Everett

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1702.

ARVO Annual Meeting Abstract June 2024

OCU400 Nuclear Hormone Receptor-Based Gene Modifier Therapy: Safety and Efficacy from Phase 1/2 Clinical Trial for Retinitis Pigmentosa Associated with NR2E3 and RHO Mutations

Byron L Lam; Arun K Upadhyay; Shankar Musunuri; Murthy Chavali; Sahar Matloob; Nalin Mehta; David G Birch; Paul Yang; Benjamin Bakall; Nieraj Jain; Jose S. Pulido; Borooah Shyamanga

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):406.

ARVO Annual Meeting Abstract June 2024

Strain Differences in Mouse Models of Pentosan Polysulfate Retinopathy

Preston Elliott Girardot; Xian Zhang; Nan Zhang; Kevin J Donaldson; Micah A Chrenek; Jana T Sellers; Andrew J. Feola; John M Nickerson; Nieraj Jain; Jeffrey H Boatright

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4651.

Physiology and Pharmacology February 2024

Pentosan Polysulfate Sodium Causes Diminished Function and Subtle Morphological Changes in Retina and RPE of Mice

PDF

Preston E. Girardot; Xian Zhang; Nan Zhang; Kevin J. Donaldson; Micah A. Chrenek; Jana T. Sellers; Andrew J. Feola; Jack Papania; John M. Nickerson; Nieraj Jain; Jeffrey H. Boatright
TAGS: mice, pentosan polysulfate sodium, retina
Invest. Ophthalmol. Vis. Sci.. 2024; 65(2):28. https://doi.org/10.1167/iovs.65.2.28

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2023

Pentosan polysulfate maculopathy: 3-year outcomes from a prospective study of disease course following drug cessation

Emily H Jung; Aaron Lindeke-Myers; Nieraj Jain

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3657.

ARVO Annual Meeting Abstract June 2023

Macular hyperautofluorescent ring characteristics among individuals with EYS -associated retinal degeneration.

Nieraj Jain

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4657.

ARVO Annual Meeting Abstract June 2022

Pentosan Polysulfate Retinopathy in Mice Involves Subtle Changes in Outer Segment Length and RPE Cell Size

Preston E. Girardot; Xian Zhang; Nan Zhang; Kevin J. Donaldson; Micah Chrenek; Jana T Sellers; Nieraj Jain; John M Nickerson; Jeffrey H Boatright

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1903 – A0049.

ARVO Annual Meeting Abstract June 2022

Readability, Suitability, and Quality of Online Health Information for Retinitis Pigmentosa & Retinitis Pigmentosa Treatment Options

Stacy Partin; Eleanor Westfall; Gregory Sanda; Kelly Muir; Kari Branham; Nieraj Jain

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3383 – A0170.

ARVO Annual Meeting Abstract June 2021

Pentosan Polysulfate Maculopathy: Prospective Longitudinal Study of Disease Course after Drug Cessation

Aaron Lindeke-Myers; Riley Lyons; Judy Brower; Nieraj Jain

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):216.

ARVO Annual Meeting Abstract June 2021

Prospective Analysis of Patient Satisfaction with Inherited Retinal Disease Clinic Visits Conducted via a Hybrid Telemedicine-based Approach

Aditya Rali; Stacy Partin; Jiong Yan; Nieraj Jain

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1540.

ARVO Annual Meeting Abstract June 2021

Patient-reported visual functioning in persons with bi-allelic USH2A variants

Elise Heon; B. Michele Melia; Laura E Bocchino; Jacque L Duncan; Allison Ayala; Chris Bradley; Isabelle Audo; Janet K Cheetham; Gislin Dagnelie; Todd Durham; Carel Hoyng; Nieraj Jain; Thiran Jayasundera; Mark E Pennesi; Christina Y Weng

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3541.

ARVO Annual Meeting Abstract June 2021

Long-term Systemic Pentosan Polysulfate Administration Causes Retinal Function Decrease with Changes in Cell Markers

Preston Girardot; Xian Zhang; Micah A Chrenek; Jana T Sellers; Nan Zhang; Nieraj Jain; John M Nickerson; Jeffrey H Boatright

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3131.

Retina November 2020

Visual Function in Pentosan Polysulfate Sodium Maculopathy

PDF

Riley J. Lyons; Judy Brower; Nieraj Jain

Invest. Ophthalmol. Vis. Sci.. 2020; 61(13):33. https://doi.org/10.1167/iovs.61.13.33

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2020

Pentosan Polysulfate Maculopathy: Disease Course after Drug Cessation

Rachel Shah; Riley Lyons; Joseph Simonett; Mark E Pennesi; Rajesh C Rao; Nieraj Jain

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1063.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Repeatability of Best Corrected Visual Acuity (BCVA) and Ellipsoid Zone (EZ) width in eyes with Retinitis Pigmentosa (RP)

Evaluation of Artificial Intelligence-Derived Peripapillary and Parafoveal Retinal Vessel Features for Cardiovascular Risk Prediction: Insights from the CRIC Study

Pars Plana Vitrectomy in Congenital X-Linked Retinoschisis

Vitreous Abnormalities in Retinitis Pigmentosa

Nonparaneoplastic Autoimmune Retinopathy: Scoping Review and Suggested Reporting Guidelines

Factors associated with microperimetry false positive responses in patients with retinitis pigmentosa (RP)

Phenotypic Spectrum of Retinal Degeneration in X-Linked PRPS1 -Related Retinopathy

OCU400 Nuclear Hormone Receptor-Based Gene Modifier Therapy: Safety and Efficacy from Phase 1/2 Clinical Trial for Retinitis Pigmentosa Associated with NR2E3 and RHO Mutations

Strain Differences in Mouse Models of Pentosan Polysulfate Retinopathy

Pentosan Polysulfate Sodium Causes Diminished Function and Subtle Morphological Changes in Retina and RPE of Mice

Pentosan polysulfate maculopathy: 3-year outcomes from a prospective study of disease course following drug cessation

Macular hyperautofluorescent ring characteristics among individuals with EYS -associated retinal degeneration.

Pentosan Polysulfate Retinopathy in Mice Involves Subtle Changes in Outer Segment Length and RPE Cell Size

Readability, Suitability, and Quality of Online Health Information for Retinitis Pigmentosa & Retinitis Pigmentosa Treatment Options

Pentosan Polysulfate Maculopathy: Prospective Longitudinal Study of Disease Course after Drug Cessation

Prospective Analysis of Patient Satisfaction with Inherited Retinal Disease Clinic Visits Conducted via a Hybrid Telemedicine-based Approach

Patient-reported visual functioning in persons with bi-allelic USH2A variants

Long-term Systemic Pentosan Polysulfate Administration Causes Retinal Function Decrease with Changes in Cell Markers

Visual Function in Pentosan Polysulfate Sodium Maculopathy

Pentosan Polysulfate Maculopathy: Disease Course after Drug Cessation

To View More...

You must be signed into an individual account to use this feature.